Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
KLOW Blend (80mg) — Research Use Only
Description: Lyophilized four-peptide research blend combining a copper-binding tripeptide, two synthetic repair peptides, and an α-MSH–derived tripeptide, supplied for research applications.
Composition: 80mg total per vial
GHK-Cu — 50mg
BPC-157 — 10mg
TB-500 (Thymosin β4 fragment) — 10mg
KPV — 10mg
Purity: ≥98% (each component)
Appearance: Blue to blue-green lyophilized powder (color attributable to the copper-peptide complex)
Storage: Store lyophilized at -20°C; reconstituted solution stable short-term at 2–8°C, protect from light. Avoid repeated freeze-thaw cycles.
Research applications: Used in published in vitro and in vivo studies investigating extracellular matrix remodeling and collagen synthesis (GHK-Cu), angiogenesis and cytoprotective signaling in tendon, muscle, and gastrointestinal tissue models (BPC-157), actin sequestration and cell migration in wound-repair models (TB-500), and melanocortin-mediated anti-inflammatory signaling via MC1R (KPV, the C-terminal tripeptide of α-MSH).
KLOW Blend (80mg) — Research Use Only
Description: Lyophilized four-peptide research blend combining a copper-binding tripeptide, two synthetic repair peptides, and an α-MSH–derived tripeptide, supplied for research applications.
Composition: 80mg total per vial
GHK-Cu — 50mg
BPC-157 — 10mg
TB-500 (Thymosin β4 fragment) — 10mg
KPV — 10mg
Purity: ≥98% (each component)
Appearance: Blue to blue-green lyophilized powder (color attributable to the copper-peptide complex)
Storage: Store lyophilized at -20°C; reconstituted solution stable short-term at 2–8°C, protect from light. Avoid repeated freeze-thaw cycles.
Research applications: Used in published in vitro and in vivo studies investigating extracellular matrix remodeling and collagen synthesis (GHK-Cu), angiogenesis and cytoprotective signaling in tendon, muscle, and gastrointestinal tissue models (BPC-157), actin sequestration and cell migration in wound-repair models (TB-500), and melanocortin-mediated anti-inflammatory signaling via MC1R (KPV, the C-terminal tripeptide of α-MSH).